Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2020 | 1 |
2021 | 2 |
2023 | 2 |
2024 | 1 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
FOLFOX-bevacizumab chemotherapy in patients with metastatic neuroendocrine tumors.
J Neuroendocrinol. 2023 Jan;35(1):e13227. doi: 10.1111/jne.13227. Epub 2023 Jan 4.
J Neuroendocrinol. 2023.
PMID: 36599808
Free PMC article.
Alkylating agent rechallenge in metastatic pancreatic neuroendocrine tumors.
De Rycke O, Walter T, Perrier M, Hentic O, Lombard-Bohas C, Coriat R, Cadiot G, Couvelard A, Ruszniewski P, Cros J, de Mestier L.
De Rycke O, et al.
Endocr Relat Cancer. 2021 Jun 11;28(7):457-466. doi: 10.1530/ERC-21-0034.
Endocr Relat Cancer. 2021.
PMID: 33979778
Item in Clipboard
High Tumor Uptake on 18F-FDOPA PET/CT Indicates Poor Prognosis in Patients with Metastatic Midgut Neuroendocrine Tumors: A Study from the Groupe d'étude des Tumeurs Endocrines and ENDOCAN-RENATEN Network.
De Rycke O, Perrier M, Ouvrard É, Mennetrey C, Lachachi C, Bando-Delaunay A, Morland D, Goichot B, Taieb D, Walter T, Cadiot G, Cros J, Hentic O, Ruszniewski P, Lebtahi R, Imperiale A, de Mestier L.
De Rycke O, et al.
J Nucl Med. 2023 Nov;64(11):1699-1705. doi: 10.2967/jnumed.123.265584. Epub 2023 Aug 31.
J Nucl Med. 2023.
PMID: 37652547
Item in Clipboard
Biomarkers of Response to Etoposide-Platinum Chemotherapy in Patients with Grade 3 Neuroendocrine Neoplasms.
Lacombe C, De Rycke O, Couvelard A, Turpin A, Cazes A, Hentic O, Gounant V, Zalcman G, Ruszniewski P, Cros J, de Mestier L.
Lacombe C, et al. Among authors: de rycke o.
Cancers (Basel). 2021 Feb 5;13(4):643. doi: 10.3390/cancers13040643.
Cancers (Basel). 2021.
PMID: 33562726
Free PMC article.
Item in Clipboard
O-positive blood type is associated with prolonged recurrence-free survival following curative resection of pancreatic neuroendocrine tumors.
De Rycke O, Védie AL, Guarneri G, Nin F, De Flori C, Hentic O, Idri S, Sauvanet A, Rebours V, Cros J, Couvelard A, Ruszniewski P, de Mestier L.
De Rycke O, et al.
Pancreatology. 2020 Dec;20(8):1718-1722. doi: 10.1016/j.pan.2020.09.014. Epub 2020 Sep 30.
Pancreatology. 2020.
PMID: 33032924
Item in Clipboard
Outcome on Mesenteric Mass Response of Small-Intestinal Neuroendocrine Tumors Treated by 177Lu-DOTATATE Peptide Receptor Radionuclide Therapy: The MesenLuth Study, a National Study from the French Group of Endocrine Tumors and Endocan-RENATEN Network.
Al Mansour L, De Mestier L, Haissaguerre M, Afchain P, Hadoux J, Lecomte T, Morland D, Cottereau AS, De Rycke O, Tlili G, Tordo J, Janier M, Deville A, Walter T.
Al Mansour L, et al. Among authors: de rycke o.
J Nucl Med. 2024 Feb 1;65(2):258-263. doi: 10.2967/jnumed.123.266063.
J Nucl Med. 2024.
PMID: 38212066
Item in Clipboard
Cite
Cite